AstraZeneca CEO Pascal Soriot Buys £7.3M of Company Stock
AZN is trading near its 52-week low of $146.1 (15% above the low).
Summary
AstraZeneca's CEO bought £7.3M of company stock on the open market, a direct show of confidence from the top executive.
Key Events · Ownership and Investor Activity · AZN
-
CEO Buys £7.3M of Stock
Pascal Soriot purchased 60,000 ordinary shares at GB£121.02 per share on 14 September 2026, totaling approximately GB£7.26M (~US$9.5M).
-
Open-Market Purchase, Not Compensation
The transaction was a direct purchase on the London Stock Exchange, not an option exercise or performance award — indicating genuine personal conviction.
-
Follows Strong Pipeline News
The purchase comes after a series of positive regulatory and clinical milestones in recent months, including FDA and EU approvals for multiple oncology assets.
Analysis · AZN · Life Sciences
CEO Pascal Soriot purchased 60,000 ordinary shares at GB£121.02 each on 14 September 2026, a total outlay of roughly GB£7.26 million (about US$9.5 million). This is a direct open-market purchase by the chief executive — real money out of pocket, not an option exercise or grant. For a company of AstraZeneca's size the dollar amount is modest, but CEO buying is a stronger conviction signal than any other insider action, and it comes amid a run of positive pipeline and regulatory news over the past three months.
How filings like this one have moved
In the 30 days to Nov 2, 2026, 32.7% of the 1910 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AZN was trading at $167.63 on NYSE in the Life Sciences sector, with a market capitalization of approximately $257.7B. The 52-week trading range was $146.10 to $212.71. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.